The Lancet COPD Commission: broader questions remain - Authors' reply

Affiliations

¹ Lung Health Center, Division of Pulmonary, Allergy, and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham, AL 35205, USA. Electronic address: mdransfield@uabmc.edu.
² Clinic of Respiratory Medicine and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Comment

Mark T Dransfield et al. Lancet. 2023.

. 2023 May 13;401(10388):1570.

doi: 10.1016/S0140-6736(23)00554-8.

¹ Lung Health Center, Division of Pulmonary, Allergy, and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham, AL 35205, USA. Electronic address: mdransfield@uabmc.edu.
² Clinic of Respiratory Medicine and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

No abstract available

Comment on

The Lancet COPD Commission: broader questions remain.
Guenette JA, Milne KM, O'Donnell DE. Guenette JA, et al. Lancet. 2023 May 13;401(10388):1568-1569. doi: 10.1016/S0140-6736(23)00555-X. Lancet. 2023. PMID: 37179112 No abstract available.
The Lancet COPD Commission: broader questions remain.
Corrêa PC. Corrêa PC. Lancet. 2023 May 13;401(10388):1568. doi: 10.1016/S0140-6736(23)00553-6. Lancet. 2023. PMID: 37179113 No abstract available.
The Lancet COPD Commission: broader questions remain.
Petousi N, Pavord ID, Couillard S. Petousi N, et al. Lancet. 2023 May 13;401(10388):1569-1570. doi: 10.1016/S0140-6736(23)00556-1. Lancet. 2023. PMID: 37179114 No abstract available.